Tailored liposomes for the treatment of bacterial infections
The invention relates to the use of empty liposomes of defined lipid composition or mixtures of empty liposomes of defined lipid composition and to the use of other lipid bilayers or monolayers of defined lipid composition for the treatment and prevention of bacterial infections. It has been found that such liposomes, in particular a two- and a four-component mixture of liposomes comprising cholesterol and sphingomyelin, liposomes consisting of sphingomyelin, liposomes comprising sphingomyelin and phosphatidylcholine, and liposomes comprising cholesterol and phosphatidylcholine efficiently sequestrate a variety of toxins secreted by bacteria, thus preventing binding of bacterial toxins to target cells and toxin-induced lysis of the target cells. Injected intravenously, liposome mixtures prevented death of laboratory mice infected with lethal doses of Staphylococcus aureus or Streptococcus pneumoniae.
1. A mixture of empty liposomes consisting of
(i) empty liposomes consisting of sphingomyelin and 40%-70% (w/w) cholesterol; and
(ii) other empty liposomes consisting of sphingomyelin,
wherein said mixture consists of a 1:1 (w/w) mixture of said empty liposomes (i) and said liposome (ii).
2. The mixture of empty liposomes according to claim 1 , wherein said empty liposomes (i) consisting of sphingomyelin and 40%-66% (w/w) cholesterol.
3. The mixture of empty liposomes according to claim 1 , wherein the amount of cholesterol of said empty liposomes (i) is 40%-60% (w/w).
4. The mixture of empty liposomes according to claim 1 , wherein the amount of cholesterol of said empty liposomes (i) is 45%-55% (w/w).
5. The mixture of empty liposomes according to claim 1 , wherein the amount of cholesterol of said empty liposomes (i) is 50% (w/w).
6. The mixture of empty liposomes according to claim 1 , wherein the cholesterol:sphingomyelin ratio of said empty liposomes (i) is about 1:1 (w/w).